Moneycontrol
HomeNewsBusinessReal EstateExclusive | Now, Sotheby’s International Realty to help Indian realtors with sales, focus on ready-to-move homes
Trending Topics

Exclusive | Now, Sotheby’s International Realty to help Indian realtors with sales, focus on ready-to-move homes

In Covid-19 times, the Keystone programme in India has added several new developments to market under its kitty with a total inventory worth Rs 10,000 crore. It’s targeting inventory worth Rs 20,000 crore by end of 2021

September 09, 2020 / 15:58 IST
Story continues below Advertisement

International property consultant (IPC) Sotheby’s International Realty has extended its Keystone programme in India raising hope of clearing unsold inventory for realtors grappling with liquidity issues, piling unsold inventory and rising trust deficit from homebuyers amid the grim COVID situation.

Sotheby’s International Realty's Keystone, a global programme that markets and sells new developments, has expanded its portfolio in India last quarter. After strengthening its footprint in Delhi, Mumbai, and Kolkata, it also plans to add Bengaluru to its portfolio.

Story continues below Advertisement

In the last quarter, the Keystone programme in India added nine new developments to market under its kitty making the total inventory worth Rs 10, 000 crore.

“Pre-COVID, India Sotheby’s International Realty had just two projects and now we have increased our focus significantly on the Keystone programme by adding about 20 seasoned real estate professionals and have been approached by several developers to partner with them,” Amit Goyal, CEO, India Sotheby’s International Realty told Moneycontrol.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show